Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, Monica, Robbins, Elissa M., Zhang-Nunes, Sandy X., Purcell, Susan M., Betensky, Rebecca A., Raju, Susan, Prada, Claudia, Greenberg, Steven M. +2 more·2006·Neurobiology of Disease

Cited by (748)

Items 301–400 of 748

  1. Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice
    Mónica Garcı́a-Alloza, Laura A. Borrelli, Bradley T. Hyman, Brian J. Bacskai · 2009 · Neurobiology of Aging
  2. Stereoisomers of Schisandrin B Are Potent ATP Competitive GSK-3β Inhibitors with Neuroprotective Effects against Alzheimer’s Disease: Stereochemistry and Biological Activity
    Hu, Xiao-Long, Guo, Cui, Hou, Ji-Qin, Feng, Jia-Hao, Zhang, Xiao-Qi, Xiong, Fei, Ye, Wen-Cai, Wang, Hao · 2019 · ACS Chemical Neuroscience
  3. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer’s disease
    van Tijn, Paula, Dennissen, Frank J.A., Gentier, Romina J.G., Hobo, Barbara, Hermes, Denise, Steinbusch, Harry W.M., Van Leeuwen, Fred W., Fischer, David F. · 2012 · Neurochemistry International
  4. Mid‐life environmental enrichment increases synaptic density in CA1 in a mouse model of Aβ‐associated pathology and positively influences synaptic and cognitive health in healthy ageing
    Kimberley E. Stuart, Anna Elizabeth King, Carmen María Fernández-Martos, Justin Dittmann, Mathew James Summers, James Clement Vickers · 2016 · The Journal of Comparative Neurology
  5. Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
    Miren Ettcheto, Elena Sánchez‐López, Laura Pons, Oriol Busquets, Jordi Olloquequi, Carlos Beas‐Zárate, Mercè Pallàs, Maria Luisa García, Carme Auladell, Jaume Folch et al. · 2017 · Redox Biology
  6. Low-dose proton radiation effects in a transgenic mouse model of Alzheimer’s disease – Implications for space travel
    Emil Rudobeck, John A. Bellone, Attila László Szűcs, Kristine Bonnick, Shalini Mehrotra, Jérôme Badaut, Gregory A. Nelson, Richard E. Hartman, Roman Vlkolinský · 2017 · PLoS ONE
  7. Anti-amyloid Therapy of Alzheimer’s Disease: Current State and Prospects
    Sergey A. Kozin, Evgeny P. Barykin, Vladimir A. Mitkevich, Alexander А. Makarov · 2018 · Biochemistry (Moscow)
  8. “What Doesn’t Kill You Makes You Stronger”: Future Applications of Amyloid Aggregates in Biomedicine
    Sherin Abdelrahman, Mawadda Alghrably, Joanna Izabela Lachowicz, Abdul-Hamid M. Emwas, Charlotte A. E. Hauser, Mariusz Jaremko · 2020 · Molecules
  9. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease
    Fernandez-Martos, Carmen M., King, Anna E., Atkinson, Rachel A.K., Woodhouse, Adele, Vickers, James C. · 2015 · Neurobiology of Aging
  10. Abnormal Clock Gene Expression and Locomotor Activity Rhythms in Two Month-Old Female APPSwe/PS1dE9 Mice
    Olaide Oyegbami, Hilary M. Collins, Marie‐Christine Pardon, Francis J. P. Ebling, David M. Heery, Paula M. Moran · 2017 · Current Alzheimer Research
  11. A small molecule Nec-1 directly induces amyloid clearance in the brains of aged APP/PS1 mice
    Seung‐Hoon Yang, Jisu Shin, Naewoo Neo Shin, Ji‐Hyun Hwang, Sung-Chul Hong, Keunwan Park, Jae Wook Lee, Sejin Lee, Seungyeop Baek, Kyeonghwan Kim et al. · 2019 · Scientific Reports
  12. High-intensity interval training and moderate-intensity continuous training alleviate β-amyloid deposition by inhibiting NLRP3 inflammasome activation in APPswe/PS1dE9 mice
    Fei Liang, Tao Huang, Baixia Li, Yongcai Zhao, Xianliang Zhang, Bo Xu · 2020 · Neuroreport
  13. Density of GABAB Receptors Is Reduced in Granule Cells of the Hippocampus in a Mouse Model of Alzheimer’s Disease
    Alejandro Martín‐Belmonte, Carolina Aguado, Rocío Alfaro‐Ruiz, Ana Esther Moreno‐Martínez, Luis de la Ossa, José Martínez Hernández, Alain Buisson, Ryuichi Shigemoto, Yugo Fukazawa, Rafael Luján · 2020 · International Journal of Molecular Sciences
  14. Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution
    Cristina Vergara, Lara Ordóñez‐Gutiérrez, Francisco G. Wandosell, Isidró Ferrer, José Antonio del Rı́o, Rosalina Gavı́n · 2014 · Molecular Neurobiology
  15. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease
    Kurt R. Stover, Richard E. Brown · 2012 · Behavioural Brain Research
  16. Resveratrol increases cerebral glycogen synthase kinase phosphorylation as well as protein levels of drebrin and transthyretin in mice: an exploratory study
    Behzad Varamini, Angelos K. Sikalidis, Kathryn L. Bradford · 2013 · International Journal of Food Sciences and Nutrition
  17. Brains from non-Alzheimer’s individuals containing amyloid deposits accelerate Aβ deposition in vivo
    Claudia A. Duran-Aniotz, Rodrigo Morales, Inés Moreno‐González, Ping Ping Hu, Claudio A. Soto · 2013 · Acta Neuropathologica Communications
  18. Targeting the γ-/β-secretase interaction reduces β-amyloid generation and ameliorates Alzheimer’s disease-related pathogenesis
    Jin Cui, Xiaoyin Wang, Xiaohang Li, Xin Wang, Chenlu Zhang, Wěi Li, Yangming Zhang, Haifeng Gu, Xin Xie, Fajun Nan et al. · 2015 · Cell Discovery
  19. Bidirectional relationships between sleep and amyloid-beta in the hippocampus
    Julien Dufort‐Gervais, Valérie Mongrain, Jonathan Brouillette · 2018 · Neurobiology of Learning and Memory
  20. Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivo
    Bettina Kass, Sarah Schemmert, Christian Zafiu, Marlene Pils, Oliver Bannach, Janine Kutzsche, Tuyen Bujnicki, Dieter Willbold · 2022 · Cell Reports Medicine
  21. Impaired cognition and cerebral glucose regulation are associated with astrocyte activation in the parenchyma of metabolically stressed APPswe/PS1dE9 mice
    Chih-Wen Yeh, Skye Hsin‐Hsien Yeh, Feng‐Shiun Shie, Wen‐Sung Lai, Hui‐Kang Liu, Tsai-Teng Tzeng, Huey-Jen Tsay, Young‐Ji Shiao · 2015 · Neurobiology of Aging
  22. Longitudinal investigation of neuroinflammation and metabolite profiles in the APP swe× PS 1Δe9 transgenic mouse model of Alzheimer's disease
    Aisling M. Chaney, Martin Bauer, Daniela Bochicchio, Alison Smigova, Michael Kassiou, Karen E. Davies, S. R. Williams, Hervé Boutin · 2017 · Journal of Neurochemistry
  23. Sepsis exacerbates Alzheimer’s disease pathophysiology, modulates the gut microbiome, increases neuroinflammation and amyloid burden
    Vijayasree Vayalanellore Giridharan, Celso S. G. Catumbela, Carlos Henrique Rocha Catalão, June‐Young Lee, Bhanu Priya Ganesh, Fabricia Cardoso Petronilho, Felipe Dal‐Pizzol, Rodrigo Morales, Tatiana Barichello · 2023 · Molecular Psychiatry
  24. Intestinal changes in permeability, tight junction and mucin synthesis in a mouse model of Alzheimer's disease
    Jing He, Yuanjie Liu, Junhua Li, Yueyang Zhao, Hanxiao Jiang, Shifang Luo, Guiqiong He · 2023 · International Journal of Molecular Medicine
  25. Silencing Apoe with divalent‐siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease
    Chantal M. Ferguson, Samuel R. Hildebrand, Bruno M.D.C. Godinho, Julianna E. Buchwald, Dimas Echeverria, Andrew H. Coles, Anastasia P. Grigorenko, Lorenc Vangjeli, Jacquelyn Sousa, Nicholas McHugh et al. · 2024 · Alzheimer s & Dementia
  26. Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis
    Zixiang Li, Yingying Lu, Yongqi Zhen, Wenke Jin, Xue Ma, Ziyue Yuan, Bo Liu, Xian-Li Zhou, Lan Zhang · 2024 · Phytomedicine
  27. Tetrahydrohyperforin Increases Adult Hippocampal Neurogenesis in Wild-Type and APPswe/PS1ΔE9 Mice
    Ana C. Abbott, Carla Calderon Toledo, Florencia C. Aránguiz, Nibaldo C. Inestrosa, Lorena Varela‐Nallar · 2013 · Journal of Alzheimer s Disease
  28. Quantifying the Uncertainty of Spontaneous Ca2+ Oscillations in Astrocytes: Particulars of Alzheimer's Disease
    Jorge J. Riera, R. Hatanaka, Takafumi Uchida, Tohru Ozaki, Ryuta Kawashima · 2011 · Biophysical Journal
  29. Impaired hippocampal-cortical coupling but preserved local synchrony during sleep in APP/PS1 mice modeling Alzheimer’s disease
    Ekaterina Zhurakovskaya, I. Ishchenko, Irina Gureviciene, Rubin Renatovich Aliev, Olli H.J. Gröhn, Heikki Tanila · 2019 · Scientific Reports
  30. High‐frequency transcranial magnetic stimulation protects APP/PS1 mice against Alzheimer’s disease progress by reducing APOE and enhancing autophagy
    Xia Chen, Guo‐Ying Dong, Lin‐Xiao Wang · 2020 · Brain and Behavior
  31. The Expression and Localisation of G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels Is Differentially Altered in the Hippocampus of Two Mouse Models of Alzheimer’s Disease
    Rocío Alfaro‐Ruiz, Alejandro Martín‐Belmonte, Carolina Aguado, Félix Hernández, Ana Esther Moreno‐Martínez, Jesús Ávila, Rafael Luján · 2021 · International Journal of Molecular Sciences
  32. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner
    Sarah Lecordier, Vincent Pons, Serge Rivest, Ayman ElAli · 2022 · Frontiers in Immunology
  33. Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer’s disease
    Nadine El Tannir El Tayara, Benoı̂t Delatour, Andreas Volk, Marc Dhénain · 2010 · Magnetic Resonance Materials in Physics Biology and Medicine
  34. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers
    Jessica Vargas, Juan Ahumada, Macarena S. Arrázola, Marco Fuenzalida, Nibaldo C. Inestrosa · 2014 · Experimental Neurology
  35. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer’s disease-like mice
    Qingyong Li, Jun Peng, Yuelian Luo, Jiaxin Zhou, Tailin Li, Lin Sen Cao, Shuling Peng, Zhiyi Zuo, Zhi Wang · 2022 · Journal of Neuroinflammation
  36. Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease
    Hongxue Luo, Qi Wu, Xiaoyang Ye, Yi Xiong, Jinyong Zhu, Junyu Xu, Yarui Diao, Duo Zhang, Maosheng Wang, Qiu JinHua et al. · 2014 · PLoS ONE
  37. Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β‑amyloid production and tau hyperphosphorylation
    Lili Zhong, Hong Liu, Weijia Zhang, Xu Liu, Bo Jiang, Hongxin Fei, Zhongren Sun · 2018 · Experimental and Therapeutic Medicine
  38. A Peephole into the Brain: Neuropathological Features of Alzheimer’s Disease Revealed by in vivo Two-Photon Imaging
    Sabine Liebscher, Melanie Meyer‐Luehmann · 2012 · Frontiers in Psychiatry
  39. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer’s disease brains.
    Dudeffant, Clémence, Vandesquille, Matthias, Herbert, Kelly, Garin, Clément M., Alves, Sandro, Blanchard, Véronique, Comoy, Emmanuel E., Petit, Fanny, Dhenain, Marc · 2017 · Scientific Reports
  40. Aerobic exercise regulates GPR81 signal pathway and mediates complement- microglia axis homeostasis on synaptic protection in the early stage of Alzheimer's disease
    Jialun Yang, Shunling Yuan, Ye Jian, Yong Lei, Zelin Hu, Qiming Yang, Xinjun Yan, Lan Zheng, Jiang-Hua Li, Wenfeng Liu · 2023 · Life Sciences
  41. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer’s Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist
    Kai Lun Chang, Ling Rong Wong, Hai Ning Pee, Shili Yang, Paul C. Ho · 2019 · Molecular Neurobiology
  42. Vitamin C deficiency increases basal exploratory activity but decreases scopolamine-induced activity in APP/PSEN1 transgenic mice
    Fiona Edith Harrison, James Michael May, Michael P. McDonald · 2009 · Pharmacology Biochemistry and Behavior
  43. Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
    Giuseppe Di Fede, Marcella Catania, Emanuela Maderna, Michela Morbin, Fabio Moda, Laura Colombo, Alessandro Rossi, Alfredo Cagnotto, Tommaso Virgilio, Luisa Palamara et al. · 2016 · Scientific Reports
  44. Trans ε viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model
    Martial Caillaud, Jérôme Guillard, Damien Richard, Serge Milin, Damien Chassaing, Marc Paccalin, Guylène Page, Agnès Rioux Bilan · 2019 · PLoS ONE
  45. Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease
    Sergey A. Kozin, Vladimir A. Mitkevich, Alexander А. Makarov · 2016 · Mendeleev Communications
  46. Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer’s Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model
    Alejandro Martín‐Belmonte, Carolina Aguado, Rocío Alfaro‐Ruiz, Makoto Itakura, Ana Esther Moreno‐Martínez, Luis de la Ossa, Elek Molnár, Yugo Fukazawa, Rafael Luján · 2020 · Frontiers in Aging Neuroscience
  47. Fluoxetine Promotes Hippocampal Oligodendrocyte Maturation and Delays Learning and Memory Decline in APP/PS1 Mice
    Feng‐lei Chao, Yi Zhang, Lei Zhang, Lin Hong Jiang, Chunni Zhou, Jing Tang, Xin Liang, Jinhua Fan, Xiaoyun Dou, Yong Cheng Tang · 2021 · Frontiers in Aging Neuroscience
  48. Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer's disease
    Zhang, Jing, Wu, Na, Wang, Shubo, Yao, Zitong, Xiao, Fuchuan, Lu, Jing, Chen, Baian · 2021 · Aging Cell
  49. Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease
    Joonhong Jun, Songyi Yang, Jung-Hun Lee, Hyungwoo Moon, Jinwoong Kim, Hoyong Jung, Daseul Im, Youri Oh, Miyoung Jang, Hyunwook Cho et al. · 2022 · European Journal of Medicinal Chemistry
  50. Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
    Jochim Reinert, Henrik Martens, Melanie Hüttenrauch, Tekla Kolbow, Lars Lannfelt, Martin Ingelsson, Anders E. Paetau, Auli Verkkoniemi‐Ahola, Thomas A. Bayer, Oliver Wirths · 2014 · Journal of Alzheimer s Disease
  51. The Proteasome Function Reporter GFPu Accumulates in Young Brains of the APPswe/PS1dE9 Alzheimer’s Disease Mouse Model
    Yanying Liu, Casey L. Hettinger, Dong Zhang, Khosrow S. Rezvani, Xuejun Wang, Hongmin Wang · 2013 · Cellular and Molecular Neurobiology
  52. Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models
    Micha M.M. Wilhelmus, Mieke de Jager, August Benjamin Smit, Rolinka J. van der Loo, Benjamin Drukarch · 2016 · Scientific Reports
  53. Cardiomyocyte Contractile Dysfunction in the APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
    Subat Turdi, Rui Guo, Anna F. Huff, Eliza M. Wolf, Bruce W. Culver, Jun Tao Ren · 2009 · PLoS ONE
  54. Chronic Allopregnanolone Treatment Accelerates Alzheimer's Disease Development in AβPPSwePSEN1ΔE9 Mice
    Sara K. S. Bengtsson, Maja Johansson, Torbjörn Carl Bäckström, Mingde Wang · 2012 · Journal of Alzheimer s Disease
  55. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease
    Dongmei Wang, Xiaoying Li, Kai Gao, Dan Lü, Xu Zhang, Chunmei Ma, Fei Ye, Lianfeng Zhang · 2013 · Pharmacology Biochemistry and Behavior
  56. Blood-brain barrier penetration of an Aβ-targeted, arginine-rich, d -enantiomeric peptide
    Nan Jiang, Daniel Frenzel, Elena Schartmann, Thomas van Groen, Inga Kadish, Nadim Jon Shah, Karl‐Josef Langen, Dieter Willbold, Antje Willuweit · 2016 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  57. Microvascular cerebral blood volume changes in aging APPswe/PS1dE9 AD mouse model: a voxel-wise approach
    Valerio Zerbi, Diane Jansen, Pieter J.W.C. Dederen, Andor A. Veltien, Bob C. Hamans, Yang Liu, Arend Heerschap, Amanda J. Kiliaan · 2012 · Brain Structure and Function
  58. Maternal separation exacerbates Alzheimer’s disease-like behavioral and pathological changes in adult APPswe/PS1dE9 mice
    Jianjun Hui, Gaifeng Feng, Caifeng Zheng, Hui Min Jin, Ning Jia · 2016 · Behavioural Brain Research
  59. Fragile X and APP: a Decade in Review, a Vision for the Future
    Cara J. Westmark · 2018 · Molecular Neurobiology
  60. Abnormal Population Responses in the Somatosensory Cortex of Alzheimer’s Disease Model Mice
    Yossi Maatuf, Edward A. Stern, Hamutal Slovin · 2016 · Scientific Reports
  61. Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's disease mouse models
    Matthew W. Granger, Hui Liu, Caitlin Fowler, Alexandre P. Blanchard, Matthew W. Taylor, Samantha Sherman, Hongbin Xu, Weidong Le, Steffany A. L. Bennett · 2018 · Journal of Neurochemistry
  62. Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model
    Chaoyuan Song, Maoyu Li, Linlin Xu, Yang Shen, Hui Yang, Mao Ding, Xiangtian Liu, Zhaohong Xie · 2018 · Neuroreport
  63. Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology
    Yee Fun Lee, Alyssa Russ, Qiuchen Zhao, Stephen J. Perle, Megi Maci, Morgan R. Miller, Steven S. Hou, Moustafa Algamal, Zhuoyang Zhao, Hanyan Li et al. · 2023 · Scientific Reports
  64. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models
    Teemu Natunen, Mari Takalo, Susanna Kemppainen, Stina Leskelä, Mikael Marttinen, Kaisa M. A. Kurkinen, Juha‐Pekka Pursiheimo, Timo Sarajärvi, Jayashree Viswanathan, Sami Gabbouj et al. · 2015 · Neurobiology of Disease
  65. Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer’s Disease
    Zhao-Jun Wang, Fang Zhao, Chen-Fang Wang, Xiumin Zhang, Yi Xiao, Fang Zhou, Meina Wu, Jun Zhang, Jin‐Shun Qi, Wei Yang · 2019 · Journal of Alzheimer s Disease
  66. Development of a novel, sensitive translational immunoassay to detect plasma glial fibrillary acidic protein (GFAP) after murine traumatic brain injury
    Emily B. Button, Wai Hang Cheng, Carlos Barrón, Honor Cheung, Asma Bashir, Jennifer Gradi Cooper, Jasmine Gill, Sophie K. Stukas, David C. Baron, Jérôme Robert et al. · 2021 · Alzheimer s Research & Therapy
  67. Modulation of amyloid precursor protein expression reduces β‐amyloid deposition in a mouse model
    Ayodeji A. Asuni, Maitea Guridi, Joanna E. Pankiewicz, Sandrine Sanchez, Martin J. Sadowski · 2014 · Annals of Neurology
  68. Human Umbilical Cord Blood-Derived Monocytes Improve Cognitive Deficits and Reduce Amyloid-β Pathology in PSAPP Mice
    Donna Darlington, Song Li, Huayan Hou, Ahsan Habib, Jun Tian, Yang Gao, Jared C. Ehrhart, Paul R. Sanberg, Darrell R. Sawmiller, Brian N. Giunta et al. · 2015 · Cell Transplantation
  69. Increased cortical beta power and spike-wave discharges in middle-aged APP/PS1 mice
    Nanxiang Jin, Arto Lipponen, Hennariikka Koivisto, Kestutis Gurevicius, Heikki Tanila · 2018 · Neurobiology of Aging
  70. Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer’s Disease
    Luisa Müller, Timo Kirschstein, Rüdiger Köhling, Angela Kuhla, Stefan Johannes Teipel · 2021 · Journal of Alzheimer s Disease
  71. Mitochondrial Deficits With Neural and Social Damage in Early-Stage Alzheimer’s Disease Model Mice
    Afzal Misrani, Sidra Tabassum, Qingwei Huo, Sumaiya Tabassum, Jinxiang Jiang, Adeel Ahmed, Xiangmao Chen, Jianwen Zhou, Jiajia Zhang, Sha Liu et al. · 2021 · Frontiers in Aging Neuroscience
  72. Cholesterol and Synaptic Compensatory Mechanisms in Alzheimer's Disease Mice Brain During Aging
    Diane Jansen, Carola I.F. Janssen, Tim Vanmierlo, Pieter J.W.C. Dederen, Daan van Rooij, Bastian Zinnhardt, Cindy L. M. Nobelen, Anna-Lena Janssen, Anne Hafkemeijer, Martina P.C. Mutsaers et al. · 2012 · Journal of Alzheimer s Disease
  73. Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer’s Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids
    Mahsa Yavari, Nishan S. Kalupahana, Breanna N. Harris, Latha Ramalingam, Yujiao Zu, Chanaka Nadeeshan Kahathuduwa, Naïma Moustaïd‐Moussa · 2025 · Nutrients
  74. High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice
    Yunhua Peng, Jing Liu, Ying Tang, Jianshu Liu, Tingting Han, Shujun Han, Hua Li, Chen Hou, Jiankang Liu, Jiangang Long · 2014 · Frontiers in Cellular Neuroscience
  75. Global cPILOT analysis of the APP/PS‐1 mouse liver proteome
    Adam R. Evans, Liqing Gu, Rodolfo Guerrero, Renã A. S. Robinson · 2015 · PROTEOMICS - CLINICAL APPLICATIONS
  76. Elevated age-related cortical iron, ferritin and amyloid plaques in APPswe/PS1ΔE9 transgenic mouse model of Alzheimer’s disease
    Helena Svobodová, Daniel Kosnáč, Z. Balázsiová, Heikki Tanila, P.O. Miettinen, Alejandra Sierra, Pavol Vitovič, Alexandra Wagner, Štefan Polák, Martin Kopáni · 2019 · Physiological Research
  77. Echinacoside Suppresses Amyloidogenesis and Modulates F-actin Remodeling by Targeting the ER Stress Sensor PERK in a Mouse Model of Alzheimer’s Disease
    Yuan Dai, Guanghui Han, Shijun Xu, Yongna Yuan, Chunyan Zhao, Tao Ma · 2020 · Frontiers in Cell and Developmental Biology
  78. IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer’s disease mouse model
    Niklas Lonnemann, Shirin Hosseini, Melanie Ohm, Robert Geffers, Karsten Hiller, Charles Anthony Dinarello, Martin Körte · 2022 · eLife
  79. Wading pools, fading memories—place navigation in transgenic mouse models of Alzheimer's disease
    Heikki Tanila · 2012 · Frontiers in Aging Neuroscience
  80. Bone Marrow-Derived Macrophages from AβPP/PS1 Mice are Sensitized to the Effects of Inflammatory Stimuli
    James P. Barrett, Aedín M. Minogue, Raasay S. Jones, Cátia S. Ribeiro, Ronan J. Kelly, Marina A. Lynch · 2015 · Journal of Alzheimer s Disease
  81. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model
    Grace M. Lloyd, Jess-Karan S. Dhillon, Kimberly-Marie M. Gorion, Cara J. Riffe, Susan Fromholt, Yuxing Xia, Benoit I. Giasson, David Borchelt · 2021 · Molecular Neurodegeneration
  82. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer’s Disease
    Henrique Correia Campos, Deidiane Elisa Ribeiro, Debora Hashiguchi, Deborah Yamazaki Hukuda, Christiane Gimenes, Simone Amaro Alves Romariz, Qing Ye, Yong Tang, Henning Ulrich, Beatriz M. Longo · 2022 · Stem Cell Reviews and Reports
  83. Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP/PS1 Mice
    Chunyang Wang, Di Shen, Yingqiu Hu, Jie Chen, Jingyun Liu, Yufei Huang, Xuebin Yu, Haiying Chu, Chenghong Zhang, Liangwei Yin et al. · 2023 · International Journal of Molecular Sciences
  84. Early brain amyloidosis in APP/PS1 mice with serum insulin-like growth factor-I deficiency
    Roseline Poirier, Ana Maria Fernandez, Ignacio Torres‐Alemán, Friedrich Metzger · 2012 · Neuroscience Letters
  85. Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding
    Devaraj Venkatapura Chandrashekar, G. Chuli Roules, Nataraj Jagadeesan, Urvashi R. Panchal, Adenike Oyegbesan, Oghenetega E. Imiruaye, Hai Zhang, Jerome Garcia, Kamaljit Kaur, Sanda Win et al. · 2024 · Neurobiology of Disease
  86. Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer’s Disease Mice
    Yangmei Huang, Baihong Guo, Bihua Shi, Qingtao Gao, Qiang Zhou · 2018 · Journal of Alzheimer s Disease
  87. Tieguanyin Oolong Tea Extracts Alleviate Behavioral Abnormalities by Modulating Neuroinflammation in APP/PS1 Mouse Model of Alzheimer’s Disease
    Hyunuk Kang, Hui Zhou, Yushan Ye, Jiangfan Yang, Zhonghua Liu, Puming He, Bo Li, Yuanyuan Wu, Yaomin Wang, Youying Tu · 2021 · Foods
  88. Mice expressing P301S mutant human tau have deficits in interval timing
    Travis Larson, Vaibhav Khandelwal, Matthew A. Weber, Mariah Leidinger, David Kyle Meyerholz, Nandakumar S. Narayanan, Qiang Zhang · 2022 · Behavioural Brain Research
  89. Gut Microbiome and Serum Metabolome Profiles of Capsaicin with Cognitive Benefits in APP/PS1 Mice
    Jun Li, Xiaojun Liao, Xuedong Yin, Zimeng Deng, Guangfen Hu, Weiwei Zhang, Feng Jiang, Liang Zhao · 2022 · Nutrients
  90. Differential effects of γ‐secretase and BACE1 inhibition on brain Aβ levels in vitro and in vivo
    Anders Brandt Elvang, Christiane Volbracht, Lars Østergaard Pedersen, Klaus Gjervig Jensen, Jens-Jakob Karlsson, Stine Anna Larsen, Arne Mørk, Tine B. Stensbøl, Jesper F. Bastlund · 2009 · Journal of Neurochemistry
  91. Magnetic resonance spectroscopy analysis of neurochemical changes in the atrophic hippocampus of APP/PS1 transgenic mice
    Shengxiang Liang, Jia Huang, Weilin Liu, Hao Jin, Long Li, Xiufeng Zhang, Binbin Nie, Ruhui Lin, Jing Tao, Shujun Zhao et al. · 2017 · Behavioural Brain Research
  92. Enriched physical environment reverses spatial cognitive impairment of socially isolated APP swe/ PS 1dE9 transgenic mice before amyloidosis onset
    Min Cao, Panpan Hu, Yanli Zhang, Yixin Yan, Christopher B. Shields, Yi‐Ping Zhang, Gang Hu, Ming Xiao · 2017 · CNS Neuroscience & Therapeutics
  93. Late-life environmental enrichment preserves short-term memory and may attenuate microglia in male APP/PS1 mice
    Kimberley E. Stuart, Anna Elizabeth King, Natalie E. King, Jessica Marie Collins, James Clement Vickers, Jenna M. Ziebell · 2019 · Neuroscience
  94. A fingerprint of amyloid plaques in a bitransgenic animal model of Alzheimer's disease obtained by statistical unmixing analysis of hyperspectral Raman data
    Emerson Alberto Fonseca, Lucas Lafetá, Renan Souza Cunha, Hudson Luiz Silva de Miranda, João Luiz Elias Campos, H. Goncalves de Medeiros, Marco Aurélio Romano‐Silva, Raigna A. Silva, Alexandre Simões Barbosa, Rafael Pinto Vieira et al. · 2019 · The Analyst
  95. Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing
    Magdolna Pákáski, Marietta Hugyecz, Péter Sántha, Gábor Jancsó, Annamária Bjelik, Ágnes Domokos, Zoltán Janka, Janos L. Kalman · 2009 · Neurochemistry International
  96. Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer’s Disease
    Florence Guillot, Susanna Kemppainen, Gregoire Lavasseur, Pasi O. Miettinen, Serge Laroche, Heikki Tanila, Sabrina Davis · 2016 · Journal of Alzheimer s Disease
  97. Disruption of leptin signalling in a mouse model of Alzheimer’s disease
    Anna Elizabeth King, Anna Brain, Kelsey Hanson, Justin Dittmann, James Clement Vickers, Carmen María Fernández-Martos · 2018 · Metabolic Brain Disease
  98. Altered brain arginine metabolism with age in the APPswe/PSEN1dE9 mouse model of Alzheimer's disease
    Pranav Vemula, Jing Yu, Jody Cicolini, Hu Zhang, Bruce G. Mockett, Wickliffe C. Abraham, Ping Liu · 2020 · Neurochemistry International
  99. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway
    Mingcui Zheng, Zhenhong Liu, Lulu Mana, Gaofeng Qin, Shuaiyang Huang, Zhuoyan Gong, Meijing Tian, Yannan He, Pengwen Wang · 2021 · Journal of Ethnopharmacology
  100. Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging
    Viharkumar Patel, Xueli Zhang, Nicolas Tautiva, Akwe Nyabera, Opeyemi Owa, Melvin Baidya, Hee Sung, Pardeep Taunk, Shahrzad Abdollahi, Stacey Charles et al. · 2015 · Current Alzheimer Research